- Report
- April 2023
- 110 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4745EUR$4,950USD£3,965GBP
- Report
- December 2024
- 85 Pages
Spain
From €3355EUR$3,500USD£2,804GBP
- Report
- August 2024
- 102 Pages
Global
From €3500EUR$3,911USD£3,027GBP
From €114EUR$119USD£95GBP
- Book
- January 2023
- 304 Pages
- Book
- October 2020
- 288 Pages
- Book
- March 2010
- 512 Pages
- Book
- September 2021
North America
- Book
- November 2016
North America
- Book
- November 2015
North America
€1525EUR$1,704USD£1,319GBP
- Book
- October 2018
- 308 Pages

The Human Papillomavirus (HPV) is a virus that can cause a variety of cancers, including cervical, anal, and oropharyngeal cancers. In the oncology market, HPV-related treatments are used to treat these cancers, as well as to prevent them from occurring in the first place. HPV vaccines are used to prevent infection with the virus, while treatments such as chemotherapy and radiation therapy are used to treat HPV-related cancers. Additionally, targeted therapies such as immunotherapy and monoclonal antibodies are used to treat HPV-related cancers.
In the HPV market, there are a number of companies that are involved in the development and manufacture of treatments and vaccines. These include Merck, GlaxoSmithKline, Sanofi, Pfizer, and AstraZeneca. Additionally, there are a number of smaller companies that are involved in the development of treatments and vaccines for HPV-related cancers. Show Less Read more